Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL) | MicrobiomeTrials← Back to trialsNCT05459753
Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2022-03-01Est. Completion: 2027-06-30
Enrollment target: 125 participants Locations- University of Michigan - Michigan Medicine, Ann Arbor, Michigan, United States
Other microbiome trials you might be interested in
Idiopathic Parkinson´s DiseaseParkinson's Disease
This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be i…
Tucson, United StatesEst. completion Sep 2027
Head and Neck Neoplasms
This is a randomized, active-controlled, open-label study of pembrolizumab given prior to surgery and pembrolizumab in c…
La Jolla, United StatesEst. completion Jul 25, 2024
Carcinoma, Non-Small-Cell Lung
The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-…
Gilbert, United StatesEst. completion May 16, 2033